CLOSE X
Company Profile
more from company profile
HomeMarkets Company Profile Financial Ratios

Financial Ratios

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE514.85-2.55 (-0.49 %)
PREV CLOSE ( ) 517.40
OPEN PRICE ( ) 521.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5995
TODAY'S LOW / HIGH ( )511.30 524.75
52 WK LOW / HIGH ( )407.4 1174.85
NSE513.90-5.35 (-1.03 %)
PREV CLOSE( ) 519.25
OPEN PRICE ( ) 520.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 513.90 (34)
VOLUME 263863
TODAY'S LOW / HIGH( ) 510.70 524.85
52 WK LOW / HIGH ( )405 1175.9
Select year
Particulars
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Operational & Financial Ratios
 
 
 
 
 
   Earnings Per Share (Rs)
22.09  
-0.28  
6.63  
-35.30  
943.16  
   CEPS(Rs)
32.48  
8.84  
14.72  
-10.92  
13.48  
   DPS(Rs)
0.00  
0.00  
0.00  
0.00  
0.00  
   Book NAV/Share(Rs)
199.01  
49.59  
50.13  
86.95  
6801.28  
   Tax Rate(%)
0.43  
101.74  
34.92  
-29.85  
28.40  
Margin Ratios
 
 
 
 
 
   Core EBITDA Margin(%)
11.18  
2.94  
8.04  
-2.50  
10.69  
   EBIT Margin(%)
9.22  
0.13  
5.38  
-4.81  
6.56  
   Pre Tax Margin(%)
8.38  
-1.08  
4.11  
-5.26  
6.31  
   PAT Margin (%)
8.35  
0.02  
2.68  
-6.83  
4.52  
   Cash Profit Margin (%)
12.07  
3.03  
5.76  
-4.25  
7.09  
Performance Ratios
 
 
 
 
 
   ROA(%)
9.42  
0.02  
3.11  
-9.64  
5.88  
   ROE(%)
18.30  
0.11  
14.61  
-33.30  
15.32  
   ROCE(%)
17.83  
0.43  
17.59  
-18.00  
19.01  
   Asset Turnover(x)
1.13  
1.26  
1.16  
1.41  
1.30  
   Sales/Fixed Asset(x)
1.99  
2.32  
2.24  
2.56  
2.35  
   Working Capital/Sales(x)
2.98  
5.72  
5.96  
6.21  
4.71  
Efficiency Ratios
 
 
 
 
 
   Fixed Capital/Sales(x)
0.50  
0.43  
0.45  
0.39  
0.43  
   Receivable days
71.09  
73.33  
86.36  
70.36  
74.60  
   Inventory Days
58.11  
59.41  
72.52  
57.27  
55.51  
   Payable days
88.12  
78.67  
92.84  
72.46  
82.54  
Valuation Parameters
 
 
 
 
 
   PER(x)
21.49  
0.00  
0.00  
0.00  
0.00  
   PCE(x)
14.61  
0.00  
0.00  
0.00  
0.00  
   Price/Book(x)
2.38  
0.00  
0.00  
0.00  
0.00  
   Yield(%)
0.00  
  
  
  
  
   EV/Net Sales(x)
1.63  
0.06  
0.11  
0.07  
0.01  
   EV/Core EBITDA(x)
12.98  
1.55  
1.08  
-3.90  
0.10  
   EV/EBIT(x)
17.65  
45.56  
2.11  
-1.53  
0.17  
   EV/CE(x)
2.19  
0.20  
0.33  
0.27  
0.03  
   M Cap / Sales
1.76  
0.00  
0.00  
0.00  
0.00  
Growth Ratio
 
 
 
 
 
   Net Sales Growth(%)
-1.44  
14.32  
-0.46  
34.87  
12.78  
   Core EBITDA Growth(%)
229.02  
-59.12  
655.88  
-122.12  
54.92  
   EBIT Growth(%)
7018.68  
-97.29  
211.33  
-198.82  
33.57  
   PAT Growth(%)
0.00  
-99.19  
138.99  
-303.82  
181.97  
   EPS Growth(%)
7932.55  
-104.25  
118.78  
-103.74  
156.73  
Financial Stability Ratios
 
 
 
 
 
   Total Debt/Equity(x)
0.00  
0.69  
0.75  
0.58  
0.11  
   Current Ratio(x)
2.55  
1.60  
1.48  
1.46  
2.00  
   Quick Ratio(x)
1.78  
1.08  
0.91  
0.90  
1.26  
   Interest Cover(x)
10.98  
0.11  
4.25  
-10.60  
26.49  
   Total Debt/Mcap(x)
0.00  
  
  
  
  
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.